| 摘要 |
The present invention provides prostamide receptor antagonist compounds that may be represented by the general formula I. wherein A, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4 </SUP>and R<SUP>6 </SUP>are as defined in the specification.
|
